NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (OTCBB: BONU), a chemical technology-based Life Science company that intends to commercialize a novel combinational chemistry-based technology, today announced Dr. Philip Tierno Jr., Ph.D., as Head of the Scientific Advisor Board for BioNeutral Group’s development of antimicrobial applications.
